retatrutide ly3437943 parkinson's disease clinical trial 🔬 — why cardiology and the gym are paying attention For years, peptides lived in bro science or medicine — rarely both. TRIUMPH-4 (Phase 3) changed that. Topline signals: • ~30% The Road towards Triple Agonists:

Weight loss and other benefits can also help with insulin resistance.

Restless leg syndrome (RLS) is a neurological disorder that can be extremely unpleasant to live with

However, the potential of ghrelin and GLP-1 to modulate reward responses in humans has not been systematically reviewed before

/PRNewswire/ -- Amble Health, a healthcare platform built to close the wealth gap in metabolic care, today announced the launch of the Amble Cares Program

Much anticipated Phase II results in obesity for Amgens GLP-1 agonist/GIP antagonist showed up to 20% weight loss, but without detailed data the drugs competitiveness is hard to ascertain.

In this paper, the authors describe the energy state-dependent regulation of the PVNGLP-1R to DVC circuit, resulting in altered food intake and metabolic health, mediated by GLP-1 receptor signalling.